Genomic sequencing giant Illumina Inc. has agreed to pay $9.8 million to settle federal allegations that it knowingly sold cybersecurity-vulnerable genetic testing systems to U.S. government agencies over a seven-year period.
The settlement, announced Thursday by the Department of Justice, represents a groundbreaking case...